Adjuvant Nivolumab Slows Muscle - Invasive Urothelial Carcinoma

Disease - free survival was longer with adjuvant nivolumab in intention - to - treat population, for those with PD - L1 expression at least 1 percent
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Surgery, Urology, Journal, Source Type: news